Qualigen Therapeutics, INC. (AIXC) — S-1/A Filings

All S-1/A filings from Qualigen Therapeutics, INC.. Browse 4 S-1/A reports with AI-powered summaries and risk analysis.

S-1/A Filings (4)

Qualigen Therapeutics Files S-1/A Amendment — Aug 22, 2024 Risk: medium
Qualigen Therapeutics, Inc. filed an S-1/A amendment on August 22, 2024, for its registration statement. The company, formerly known as Ritter Pharmaceuticals I
Qualigen Therapeutics Files S-1/A Amendment — Aug 9, 2024 Risk: medium
Qualigen Therapeutics, Inc. filed an S-1/A amendment on August 9, 2024, for its registration statement. The company, formerly known as Ritter Pharmaceuticals In
Qualigen Therapeutics Files S-1/A Amendment — Aug 7, 2024 Risk: medium
Qualigen Therapeutics, Inc. filed an S-1/A amendment on August 7, 2024, related to its registration statement (No. 333-272623). The company, formerly known as R
Qualigen Therapeutics, Inc. Files Amendment to S-1 Registration Statement — May 6, 2024 Risk: low
Qualigen Therapeutics, Inc. (AIXC) filed a Amended IPO Registration (S-1/A) with the SEC on May 6, 2024. Qualigen Therapeutics, Inc. filed an Amendment No. 2 to

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX